Trial intelligence / Profile preview

Procaterol hydrochloride plus montelukast versus montelukast alone for cough-variant asthma in children

ChiCTR-IIR-17012223Phase 4Completed

Sponsor
Beijing Children's Hospital
Start
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of procaterol and montelukast in cough variant asthma (CVA) (2 arms), sponsored by Beijing Children's Hospital. Primary endpoint: Cough score. Started May 2013; status: completed.

02

Drugs

procaterolmontelukast
03

Conditions

cough variant asthma (CVA)

Beyond the preview

Go deeper on ChiCTR-IIR-17012223.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IIR-17012223.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call